Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-11-06
1997-12-30
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548251, C07D 31405
Patent
active
057031070
ABSTRACT:
The present invention is directed to a new class of 3-amido and 3-sulfamido-indolyl NMDA antagonists and their use in the treatment of a number of disease states.
REFERENCES:
patent: 4675332 (1987-06-01), Conner et al.
patent: 4748183 (1988-05-01), Cetenko et al.
patent: 4774240 (1988-09-01), Boshagen et al.
patent: 4851406 (1989-07-01), Meriens et al.
patent: 4960786 (1990-10-01), Salituro et al.
A. Monge et al., J. Heterocyclic Chem., 24, pp. 437-439 (1987).
A.S. Bailey et al., J.C.S. Perkin I, pp. 1602-1606.
J.T. Greenamyre, Arch Neurol., vol. 43, pp. 1058-1063 (1986).
J.W. Olney, Biol. Psychiatry 26, pp. 505-525 (1989).
M.B. Robinson et al., FASEB J. 1:446-455 (1987).
R.Dingledine et al., TIPS vol.11, 334-338 (1990).
Salituro et al., Chem. Abstracts., vol. 116, No. 83486a (1991).
Baron Bruce M.
Salituro Francesco G.
Daus Donald G.
Merrell Pharmaceuticals Inc.
Sayles Michael J.
LandOfFree
3-aminoindolyl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-aminoindolyl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-aminoindolyl derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-202731